t
Dr. Martens plc announced a restructure in Permira V Fund's ownership, whereby IngreLux S.àr.l. transferred its 38.46% shareholding to IngreGrsy Limited. This change, effective 11 June 2024, resulted in IngreGrsy Limited replacing IngreLux S.àr.l. as the company's largest shareholder and in the relationship agreement.
| Date | 12 Jun 2024 |
| Time | 16:35:00 |
| Category | Miscellaneous |
| ID | 2034S |
12 June 2024
Dr. Martens plc
Technical change in Permira ownership structure
Dr. Martens plc ('the Company') makes this announcement in connection with the TR-1 announcements released today regarding the notification of major holdings by IngreGrsy Limited and IngreLux S.àr.l..
Permira V Fund has undergone a restructure of its holding of shares in Dr. Martens plc, whereby IngreGrsy Limited (a newly incorporated Guernsey company) has replaced IngreLux S.àr.l. (a Luxembourg entity) in the Permira Fund V structure and IngreLux S.àr.l has transferred its 38.46% shareholding in the Company to IngreGrsy Limited. As a result, IngreGrsy Limited replaced IngreLux S.àr.l. as the Company's largest shareholder with effect from 11 June 2024. The Company, IngreLux S.àr.l. and IngreGrsy Limited also entered into a novation agreement in order for IngreGrsy Limited to replace IngreLux S.à r.l. in the relationship agreement with the Company. The Permira V Fund ownership structure is otherwise unchanged and remains ultimately controlled by Permira V GP Limited and advised by Permira Advisers LLP.
Enquiries
Investors and analysts
Bethany Barnes, Director of Investor Relations [email protected] +44 7825 187465
Beth Callum, Investor Relations Manager [email protected] +44 203 995 2644
Company Secretariat
Paul Rolling, Assistant Company Secretary [email protected]